Skip to main content

JPMORGAN CHASE & CO

Position in PTGX — Protagonist Therapeutics, Inc

CIK 19617 NEW YORK, NY

Position in PTGX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$22,444,150
+$4,211,006 QoQ
Shares Held
183,098
+5.8% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. PTGX ranks #58 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,444,150 183,098
2026-03-31 $18,233,144 172,990
2025-12-31 $13,563,900 155,300
2025-09-30 $16,766,931 252,400
2025-06-30 $24,633,395 445,692
2025-03-31 $22,675,955 468,899
2024-12-31 $22,271,310 576,977
2024-09-30 $22,634,325 502,985
2024-06-30 $13,048,772 376,588
2024-03-31 $6,869,137 237,440
2023-12-31 $9,425,283 411,046
2023-09-30 $3,874,596 232,290
2023-06-30 $7,311,206 264,707
2023-03-31 $2,441,059 106,133
2022-12-31 $3,307,496 303,162
2022-09-30 $1,479,960 175,559
2022-06-30 $953,113 120,495
2022-03-31 $1,638,251 69,183
2021-12-31 $14,926,692 436,453
2021-09-30 $7,596,474 428,695
2021-06-30 $19,452,248 433,428
2021-03-31 $15,148,831 584,897
2020-12-31 $14,172,620 703,007
2020-09-30 $15,341,236 784,718
2020-06-30 $14,796,677 837,864
2020-03-31 $6,234,070 883,013